• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙酰甲胆碱激发试验后沙丁胺醇诱导的支气管扩张过程中呼气峰流速(PEF)和第一秒用力呼气容积(FEV)变化的关系

Relation of Changes in PEF and FEV During Salbutamol-Induced Bronchodilation After Methacholine Challenge Test.

作者信息

Csonka Leon L, Tikkakoski Antti, Vuotari Liisa, Karjalainen Jussi, Lehtimäki Lauri

机构信息

Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.

Department of Clinical Physiology and Nuclear Medicine, Tampere University Hospital, Tampere, Finland.

出版信息

Pulm Med. 2025 Jul 7;2025:7675935. doi: 10.1155/pm/7675935. eCollection 2025.

DOI:10.1155/pm/7675935
PMID:40661699
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12259322/
Abstract

Asthma diagnosis can be confirmed by observing significant bronchodilator response (BDR) through peak expiratory flow (PEF) at home or forced expiratory volume in 1 s (FEV) via spirometry in a clinical setting. We aimed to use the administration of salbutamol after a methacholine challenge test as a model of bronchodilation to study how accurately the change in PEF predicts improvement in lung function, as defined by an increase in FEV. We analyzed 869 adult patients who were administered salbutamol after a methacholine challenge. To compare relative changes in PEF and FEV during bronchodilation, we used regression analysis and constructed a Bland and Altman plot. ROC analysis, sensitivity, specificity, positive and negative predictive values, and kappa coefficient assessed how precisely increases in PEF detected a 12% and 0.2-L improvement in FEV. The average relative increase in FEV was significantly greater than that in PEF. The area under the curve in the ROC analysis was 0.844 for PEF change to detect a 12% and 0.2-L increase in FEV. The kappa values for changes in PEF and FEV ranged from fair to moderate. BDR detected by the recommended 15% and 60 L/min cut-off for PEF identified less than half of true positives, while a 10% cut-off correctly identified close to 75% of them. PEF increase is not a reliable measure of BDR in comparison to FEV increase, and a 10% improvement in PEF was the least inaccurate cut-off. Substituting the PEF meter with a handheld spirometer should be further investigated for asthma home monitoring.

摘要

通过在家中使用呼气峰值流速(PEF)观察显著的支气管扩张剂反应(BDR),或在临床环境中通过肺量计测量一秒用力呼气量(FEV),可以确诊哮喘。我们旨在将乙酰甲胆碱激发试验后给予沙丁胺醇作为支气管扩张模型,以研究PEF变化预测肺功能改善(定义为FEV增加)的准确程度。我们分析了869例乙酰甲胆碱激发试验后给予沙丁胺醇的成年患者。为了比较支气管扩张期间PEF和FEV的相对变化,我们使用回归分析并构建了布兰德-奥特曼图。ROC分析、敏感性、特异性、阳性和阴性预测值以及kappa系数评估了PEF增加检测FEV增加12%和0.2升改善的精确程度。FEV的平均相对增加显著大于PEF。ROC分析中,PEF变化检测FEV增加12%和0.2升时曲线下面积为0.844。PEF和FEV变化的kappa值从中度到良好不等。推荐的PEF 15%和60升/分钟截断值检测到的BDR识别出的真阳性不到一半,而10%的截断值正确识别了近75%的真阳性。与FEV增加相比,PEF增加不是BDR的可靠测量指标,PEF改善10%是最不准确的截断值。对于哮喘家庭监测,用手持式肺量计替代PEF仪应进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c93d/12259322/fbac60b1a3ac/PM2025-7675935.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c93d/12259322/55a648798a65/PM2025-7675935.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c93d/12259322/4f4fae2beab6/PM2025-7675935.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c93d/12259322/fbac60b1a3ac/PM2025-7675935.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c93d/12259322/55a648798a65/PM2025-7675935.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c93d/12259322/4f4fae2beab6/PM2025-7675935.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c93d/12259322/fbac60b1a3ac/PM2025-7675935.003.jpg

相似文献

1
Relation of Changes in PEF and FEV During Salbutamol-Induced Bronchodilation After Methacholine Challenge Test.乙酰甲胆碱激发试验后沙丁胺醇诱导的支气管扩张过程中呼气峰流速(PEF)和第一秒用力呼气容积(FEV)变化的关系
Pulm Med. 2025 Jul 7;2025:7675935. doi: 10.1155/pm/7675935. eCollection 2025.
2
Relation of changes in peak expiratory flow (PEF) and forced expiratory volume in 1 s (FEV) during bronchoconstriction.支气管收缩过程中呼气峰流速(PEF)和 1 秒用力呼气量(FEV)变化的关系。
Clin Physiol Funct Imaging. 2024 Nov;44(6):447-453. doi: 10.1111/cpf.12898. Epub 2024 Jun 22.
3
[Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].[氯化乙酰甲胆碱支气管激发试验标准技术规范(2023年)]
Zhonghua Jie He He Hu Xi Za Zhi. 2024 Feb 12;47(2):101-119. doi: 10.3760/cma.j.cn112147-20231019-00247.
4
Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children.福莫特罗与布地奈德联合用于成人和儿童慢性哮喘的维持和缓解治疗与联合吸入器维持治疗的对比
Cochrane Database Syst Rev. 2013 Dec 16;2013(12):CD009019. doi: 10.1002/14651858.CD009019.pub2.
5
The Advantages of FEV Percent Predicted Change During Bronchial Challenge Testing.支气管激发试验中预计FEV变化百分比的优势
Lung. 2025 Jul 5;203(1):73. doi: 10.1007/s00408-025-00823-5.
6
The Predictive Value of Baseline Spirometry, Age, and Gender for Airway Hyper-Responsiveness in Adults With Suspected Asthma.基线肺量计检查、年龄和性别对疑似哮喘成人气道高反应性的预测价值
Respir Care. 2025 Jul;70(7):847-854. doi: 10.1089/respcare.12039. Epub 2025 Feb 20.
7
Comparison of oscillometry with lung function parameters between patients with stable bronchial asthma with airflow obstruction and chronic obstructive pulmonary disease.气流受限的稳定期支气管哮喘患者与慢性阻塞性肺疾病患者的振荡法与肺功能参数比较
BMC Pulm Med. 2025 Jul 10;25(1):333. doi: 10.1186/s12890-025-03754-2.
8
The diagnostic value of bronchodilator response in differentiating asthma, COPD, and ACO in fixed airflow obstruction: a retrospective study.支气管扩张剂反应在鉴别固定性气流受限中的哮喘、慢性阻塞性肺疾病和哮喘-慢性阻塞性肺疾病重叠综合征的诊断价值:一项回顾性研究
BMC Pulm Med. 2025 Jul 2;25(1):291. doi: 10.1186/s12890-025-03764-0.
9
Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children.长效β2受体激动剂与吸入性糖皮质激素联合用于儿童慢性哮喘治疗。
Cochrane Database Syst Rev. 2015 Nov 24;2015(11):CD007949. doi: 10.1002/14651858.CD007949.pub2.
10
Effect of the S-nitrosoglutathione reductase inhibitor N6022 on bronchial hyperreactivity in asthma.N6022 对哮喘支气管高反应性的影响:一种 S-亚硝基谷胱甘肽还原酶抑制剂。
Immun Inflamm Dis. 2018 Jun;6(2):322-331. doi: 10.1002/iid3.220. Epub 2018 Apr 11.

本文引用的文献

1
Relation of changes in peak expiratory flow (PEF) and forced expiratory volume in 1 s (FEV) during bronchoconstriction.支气管收缩过程中呼气峰流速(PEF)和 1 秒用力呼气量(FEV)变化的关系。
Clin Physiol Funct Imaging. 2024 Nov;44(6):447-453. doi: 10.1111/cpf.12898. Epub 2024 Jun 22.
2
Relation of changes in PEF and FEV1 in exercise challenge in children.运动激发试验中 PEF 和 FEV1 变化的关系。
Clin Physiol Funct Imaging. 2024 Mar;44(2):179-185. doi: 10.1111/cpf.12864. Epub 2023 Nov 23.
3
Clinic vs Home Spirometry for Monitoring Lung Function in Patients With Asthma.
哮喘患者肺功能监测的诊所与家庭肺功能测定比较。
Chest. 2023 Nov;164(5):1087-1096. doi: 10.1016/j.chest.2023.06.029. Epub 2023 Jun 27.
4
Feasibility and acceptability of home monitoring with portable spirometry in young adults with asthma.便携式肺功能仪家庭监测在哮喘青年中的可行性和可接受性。
J Asthma. 2023 Jul;60(7):1474-1479. doi: 10.1080/02770903.2022.2160345. Epub 2023 Jan 2.
5
Pulmonary Function Tests in Childhood Asthma: Which indices are Better for Assessment of Severity?儿童哮喘的肺功能测试:哪些指标更适合评估严重程度?
Indian J Pediatr. 2023 Jun;90(6):566-571. doi: 10.1007/s12098-022-04258-1. Epub 2022 Jul 14.
6
European Respiratory Society guidelines for the diagnosis of asthma in adults.欧洲呼吸学会成人哮喘诊断指南。
Eur Respir J. 2022 Sep 7;60(3). doi: 10.1183/13993003.01585-2021. Print 2022 Sep.
7
ERS/ATS technical standard on interpretive strategies for routine lung function tests.ERS/ATS 技术标准:常规肺功能测试的解释策略。
Eur Respir J. 2022 Jul 13;60(1). doi: 10.1183/13993003.01499-2021. Print 2022 Jul.
8
Use of ROC curves in clinical and experimental studies.ROC曲线在临床和实验研究中的应用。
J Vasc Bras. 2020 Dec 11;19:e20200186. doi: 10.1590/1677-5449.200186.
9
Home self-monitoring in patients with asthma using a mobile spirometry system.哮喘患者使用移动肺功能仪进行家庭自我监测。
J Asthma. 2021 Apr;58(4):505-511. doi: 10.1080/02770903.2019.1709864. Epub 2020 Jan 6.
10
Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement.肺功能测定标准化 2019 修订版。美国胸科学会和欧洲呼吸学会官方技术声明。
Am J Respir Crit Care Med. 2019 Oct 15;200(8):e70-e88. doi: 10.1164/rccm.201908-1590ST.